These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34533265)

  • 41. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 42. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.
    Atzori L; Pinna AL; Ferreli C; Aste N
    Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Segmental lesions in pityriasis rosea: a rare presentation.
    Zawar V; Godse K
    Skinmed; 2011; 9(6):382-4. PubMed ID: 22256628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
    [No Abstract]   [Full Text] [Related]  

  • 47. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
    Potestio L; Martora F; Cacciapuoti S; Megna M; Villani A; Ruggiero A
    Clin Cosmet Investig Dermatol; 2024; 17():51-57. PubMed ID: 38222859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea.
    Kosuge H; Tanaka-Taya K; Miyoshi H; Amo K; Harada R; Ebihara T; Kawahara Y; Yamanishi K; Nishikawa T
    Br J Dermatol; 2000 Oct; 143(4):795-8. PubMed ID: 11069458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine.
    Huang L; Yao Z; Zhang J
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e9-e11. PubMed ID: 34492136
    [No Abstract]   [Full Text] [Related]  

  • 50. HHV 6-7 reactivation causing Pityriasis Rosea and labyrinthitis: A case report.
    El-Hussein M; El-Tawil C; Nakhle R; Souaiby N
    Am J Emerg Med; 2020 Sep; 38(9):1969.e1-1969.e3. PubMed ID: 32553563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 52. Oropharyngeal lesions in pityriasis rosea.
    Ciccarese G; Broccolo F; Rebora A; Parodi A; Drago F
    J Am Acad Dermatol; 2017 Nov; 77(5):833-837.e4. PubMed ID: 28728872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
    Adya KA; Inamadar AC; Albadri W
    Dermatol Ther; 2021 Sep; 34(5):e15040. PubMed ID: 34165237
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei.
    Wong WR; Tsai CY; Shih SR; Chan HL
    J Formos Med Assoc; 2001 Jul; 100(7):478-83. PubMed ID: 11579614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.
    Drago F; Ciccarese G; Broccolo F; Cozzani E; Parodi A
    Dermatology; 2015; 231(1):9-14. PubMed ID: 25997658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An update on pityriasis rosea and other similar childhood exanthems.
    Browning JC
    Curr Opin Pediatr; 2009 Aug; 21(4):481-5. PubMed ID: 19502983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea.
    Alzahrani NA; AlJasser MI
    Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin.
    Drago F; Ranieri E; Malaguti F; Battifoglio ML; Losi E; Rebora A
    Dermatology; 1997; 195(4):374-8. PubMed ID: 9529560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pityriasis rosea is not associated with human herpesvirus 7.
    Kempf W; Adams V; Kleinhans M; Burg G; Panizzon RG; Campadelli-Fiume G; Nestle FO
    Arch Dermatol; 1999 Sep; 135(9):1070-2. PubMed ID: 10490111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular study of recent virus and its relationship to Pityriasis rosea.
    Kawen AA
    J Popul Ther Clin Pharmacol; 2022; 29(1):e109-e115. PubMed ID: 35686902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.